Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Guided Self-Help Treatment for Binge Eating Disorder (BEST)

This study has been completed.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Kaiser Permanente
ClinicalTrials.gov Identifier:
NCT00158340
First received: September 7, 2005
Last updated: November 4, 2011
Last verified: November 2011

September 7, 2005
November 4, 2011
August 2004
July 2008   (final data collection date for primary outcome measure)
Frequency of binge eating [ Time Frame: Measured at post-treatment, Week 12, Month 6, and Year 1 ] [ Designated as safety issue: No ]
Frequency of binge eating at baseline, Week 12, Month 6, and Month 12
Complete list of historical versions of study NCT00158340 on ClinicalTrials.gov Archive Site
  • Frequency of inappropriate compensatory behaviors, dietary restraint, over-valuation of weight/shape, functional impairment, self-esteem, and social impairment [ Time Frame: Measured at post-treatment, Week 12, Month 6, and Year 1 ] [ Designated as safety issue: No ]
  • Body weight [ Time Frame: Measured at post-treatmentand Year 1 ] [ Designated as safety issue: No ]
  • Frequency of inappropriate compensatory behaviors, dietary restraint, overevaluation of weight/shape, functional impairment, self-esteem, and social impairment assessed at baseline, 12 weeks, 6 months, and 12 months
  • body weight assessed at baseline and 12 months
Not Provided
Not Provided
 
Guided Self-Help Treatment for Binge Eating Disorder
Binge Eating Self-Guided Treatment (BEST)

This study will determine the effectiveness of guided self-help treatment in treating individuals with binge eating disorder (BED).

Binge eating disorder (BED) is a serious condition characterized by compulsive overeating and feelings of powerlessness. The condition often has a negative impact on both physical and emotional health. This study will examine ways to help people determine whether they have BED and will test whether guided self-help (GSH) treatment is effective in treating BED.

Participants will be randomly assigned to receive either GSH treatment or usual clinical care (which may include general support and talk therapy) for 3 months. The GSH treatment is a cognitive behavioral therapy-based program that will be administered over 8 sessions. Participants receiving GSH will be given a book that focuses on dealing with BED; they will also meet with a therapist regularly to have their progress monitored. The Eating Disorders Examination (EDE), self-reports, questionnaires, and surveys will be used to assess participants. Assessments will be conducted at study entry, at Weeks 2 and 4 of the treatment, at the end of the treatment, and at 6 and 12 months post-treatment.

Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
  • Eating Disorders
  • Bulimia
  • Behavioral: Guided self-help cognitive behavioral therapy (CBT)
    Participants receive eight sessions of guided self-help CBT.
  • Behavioral: Usual clinical care
    Control group participants receive treatment as usual.
  • Experimental: 1
    Participants will receive guided self-help cognitive behavioral therapy
    Intervention: Behavioral: Guided self-help cognitive behavioral therapy (CBT)
  • Active Comparator: 2
    Participants will receive treatment as usual
    Intervention: Behavioral: Usual clinical care
Lynch FL, Striegel-Moore RH, Dickerson JF, Perrin N, Debar L, Wilson GT, Kraemer HC. Cost-effectiveness of guided self-help treatment for recurrent binge eating. J Consult Clin Psychol. 2010 Jun;78(3):322-33. doi: 10.1037/a0018982.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
284
July 2008
July 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Diagnosis of binge eating disorder (BED) bulimia nervosa (BN), or spectrum BN, defined as recurrent binge eating at least once a week for 3 months
  • Body mass index (BMI) between 18 and 45
  • Continuous membership in the Kaiser Permanente Northwest Division for at least 12 months prior to study entry

Exclusion Criteria:

  • Diagnosis of anorexia nervosa or psychotic disorder
  • Significant organic brain syndromes, retardation, pervasive developmental disorder, or autism
  • At risk for suicide
  • Pregnancy
Both
18 Years to 50 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00158340
R01 MH66966, R01MH066966, DSIR 83-ATAS
Yes
Kaiser Permanente
Kaiser Permanente
National Institute of Mental Health (NIMH)
Principal Investigator: Ruth H. Striegel-Moore, PhD Wesleyan University
Kaiser Permanente
November 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP